167 related articles for article (PubMed ID: 9212731)
21. Corticomedullary differentiation and maturational arrest in thymomas.
Ströbel P; Hartmann E; Rosenwald A; Kalla J; Ott G; Friedel G; Schalke B; Kasahara M; Tomaru U; Marx A
Histopathology; 2014 Mar; 64(4):557-66. PubMed ID: 24236644
[TBL] [Abstract][Full Text] [Related]
22. L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
J Surg Oncol; 2009 Jun; 99(7):433-8. PubMed ID: 19347882
[TBL] [Abstract][Full Text] [Related]
23. Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis.
Marx A; Wilisch A; Schultz A; Greiner A; Magi B; Pallini V; Schalke B; Toyka K; Nix W; Kirchner T; Müller-Hermelink HK
Am J Pathol; 1996 Jun; 148(6):1839-50. PubMed ID: 8669470
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor expression in invasive thymoma.
Henley JD; Koukoulis GK; Loehrer PJ
J Cancer Res Clin Oncol; 2002 Mar; 128(3):167-70. PubMed ID: 11935304
[TBL] [Abstract][Full Text] [Related]
25. [Thymoma with epithelial micronodules and lymphoid hyperplasia: six cases of a rare and equivocal subtype].
Thomas De Montpréville V; Zemoura L; Dulmet E
Ann Pathol; 2002 Jun; 22(3):177-82. PubMed ID: 12410100
[TBL] [Abstract][Full Text] [Related]
26. Estrogen inhibits cell proliferation through in situ production in human thymoma.
Ishibashi H; Suzuki T; Suzuki S; Moriya T; Kaneko C; Nakata T; Sunamori M; Handa M; Kondo T; Sasano H
Clin Cancer Res; 2005 Sep; 11(18):6495-504. PubMed ID: 16166425
[TBL] [Abstract][Full Text] [Related]
27. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
[TBL] [Abstract][Full Text] [Related]
28. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
Hattori H; Tateyama H; Tada T; Saito Y; Yamakawa Y; Eimoto T
Virchows Arch; 2000 Jan; 436(1):20-7. PubMed ID: 10664158
[TBL] [Abstract][Full Text] [Related]
29. Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas.
Meister M; Schirmacher P; Dienemann H; Mechtersheimer G; Schnabel PA; Kern MA; Herpel E; Xu EC; Muley T; Thomas M; Rieker RJ
Cancer Lett; 2007 Apr; 248(2):186-91. PubMed ID: 16919868
[TBL] [Abstract][Full Text] [Related]
30. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3?
Laeng RH; Eimoto T; Kuo TT; Zettl A; Marx A; Moschopulos M; Tateyama H; Shimokawa K
Pathol Res Pract; 2006; 202(10):697-704. PubMed ID: 16887284
[TBL] [Abstract][Full Text] [Related]
31. Thymoma: an integrated clinicopathological and immunohistochemical study.
Ring NP; Addis BJ
J Pathol; 1986 Aug; 149(4):327-37. PubMed ID: 2428964
[TBL] [Abstract][Full Text] [Related]
32. Tissue distribution of very late activation antigens-1/6 and very late activation antigen ligands in the normal thymus and in thymoma.
Ruco LP; Paradiso P; Pittiglio M; Diodoro MG; Gearing AJ; Mainiero F; Gismondi A; Santoni A; Baroni CD
Am J Pathol; 1993 Mar; 142(3):765-72. PubMed ID: 8456937
[TBL] [Abstract][Full Text] [Related]
33. Expression of E-cadherin and alpha- and beta-catenins in thymoma.
Pan CC; Ho DM; Chen WY; Chiang H; Fahn HJ; Wang LS
J Pathol; 1998 Feb; 184(2):207-11. PubMed ID: 9602713
[TBL] [Abstract][Full Text] [Related]
34. [Correlation between clinical aggressiveness of thymic epithelial tumors and expression of tumor suppressor gene products (p53, p27)].
Fukiwake N; Kase S; Yamazaki K; Yano T; Sugimachi K
Fukuoka Igaku Zasshi; 1999 Aug; 90(8):339-41. PubMed ID: 10496046
[TBL] [Abstract][Full Text] [Related]
35. CD5 expression in thymic carcinoma.
Hishima T; Fukayama M; Fujisawa M; Hayashi Y; Arai K; Funata N; Koike M
Am J Pathol; 1994 Aug; 145(2):268-75. PubMed ID: 7519823
[TBL] [Abstract][Full Text] [Related]
36. Comparative morphologic and immunohistochemical investigation of spontaneously occurring thymomas in a colony of European hamsters.
Brandes K; Fend F; Monecke S; Teifke JP; Breuer W; Hermanns W
Vet Pathol; 2004 Jul; 41(4):346-52. PubMed ID: 15232134
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma.
Katsuya Y; Fujita Y; Horinouchi H; Ohe Y; Watanabe S; Tsuta K
Lung Cancer; 2015 May; 88(2):154-9. PubMed ID: 25799277
[TBL] [Abstract][Full Text] [Related]
38. Absence of gene mutations in KIT-positive thymic epithelial tumors.
Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors.
Sogawa K; Kondo K; Fujino H; Takahashi Y; Miyoshi T; Sakiyama S; Mukai K; Monden Y
Cancer; 2003 Nov; 98(9):1822-9. PubMed ID: 14584061
[TBL] [Abstract][Full Text] [Related]
40. Thymoma: a pathological study of 50 cases.
Vaideeswar P; Padmanabhan A; Deshpande JR; Pandit SP
J Postgrad Med; 2004; 50(2):94-7. PubMed ID: 15235201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
